57 articles
Minor hallucinations predict Lewy body dementia with 80% accuracy, new research finds, offering doctors a key tool to distinguish it from Alzheimer's.
Vision problems after stroke are common yet routinely missed; early screening and rehabilitation can reduce fall risk and help patients regain.
Fewer than 3% of Alzheimer's patients follow all brain health guidelines, even those actively pursuing the latest drug treatments.
Women using estrogen-only therapy had 35% lower odds of Alzheimer's brain changes at autopsy, a new Stanford-led study finds.
Dementia and Alzheimer's aren't the same thing, and knowing the difference shapes treatment, care planning, and the questions your doctor needs to hear.
Managing blood pressure, diabetes, and smoking in midlife could add 13 dementia-free years, a major study of 12,000 adults finds.
The first FDA-cleared stem cell therapy for stroke and brain injury enters human trials, with early data showing 92% of patients achieving meaningful.
Limiting sugar in a child's first 1,000 days is linked to a 46% lower Alzheimer's risk, plus younger-looking brains decades later.
A new brain signal called ERNA predicts the best Parkinson's DBS electrode site 80% of the time, making surgery faster and less grueling for patients.
Depression hits 50% of Parkinson's patients, and a Yale study finds it has its own brain signature that standard antidepressants fail to address.
Some people accumulate Alzheimer's plaques yet never develop dementia, and a new study reveals their brain's immune cells may hold the key.
Magnetic nanoparticles injected into mouse brains improved Parkinson's symptoms as effectively as a brain pacemaker, without permanently implanted.
Myelin damage may drive long-term TBI symptoms, and new research suggests restoring it could actually reverse brain aging measured by MRI.
Sleeping more than 8.5 hours nightly may signal early Alzheimer's changes, with new research linking long sleep to elevated tau proteins in the blood.
A blood test for p-tau217 can predict Alzheimer's risk up to 10 years early, with 78% of high-level patients developing cognitive decline.
Biogen's Alzheimer's drug diranersen failed its primary trial goal yet still slowed cognitive decline 26%, prompting a bold push into Phase 3 testing.
A gut chemical called sodium butyrate may prevent post-traumatic epilepsy after brain injury by blocking inflammation before seizures ever develop.
Three new Alzheimer's drugs target DNA damage, brain cholesterol, and inflammation, signaling a shift toward multi-pathway therapies for dementia.
Nearly 4 in 10 former NFL players have tinnitus, with concussion history strongly linked to the condition and worse mental health outcomes.
Gut bacteria that produce vitamin B6 may fuel dopamine production and ease Parkinson's motor symptoms, but the same bacteria can block levodopa medication.
A University of Florida study found glucosamine, a popular joint supplement, raises Alzheimer's progression risk by 25% in those with cognitive impairment.
Scientists are targeting tau protein with a new drug class to slow Alzheimer's disease, with Phase 2 trial results expected this year.
Scientists found that a brain protein called Arc carries toxic tau between neurons, revealing a new target that could slow Alzheimer's spread.
PrimeC, a new Alzheimer's drug, showed biomarker changes across amyloid, tau, and TDP-43 in a small Phase 2 trial, hinting at a multi-target treatment.
A common virus contracted decades earlier may silently trigger Parkinson's disease, new Texas A&M research using a natural animal model confirms.
UCLA researchers found people exposed to chlorpyrifos face 2.5 times the Parkinson's disease risk, with lab studies revealing the pesticide disrupts the.
Adaptive deep brain stimulation now adjusts electrical impulses in real time, and UCSF is testing automated tools to bring this FDA-approved Parkinson's.
New brain imaging data links traumatic brain injury to higher tau levels in veterans, suggesting head injuries may accelerate Alzheimer's disease decades.
Heavy drinking may speed up brain aging and raise Alzheimer's risk, but experts say cutting back could meaningfully lower your dementia risk.
A new clinical trial found omega-3 fish oil supplements alone won't protect your brain; they only work when paired with a healthy lifestyle.
Older adults with dementia, stroke, or Parkinson's disease face triple the traumatic brain injury risk, making early fall screening critical after.
Teen football players with concussions face more than double the risk of high blood pressure, a finding that reshapes how head injuries in young athletes.
Only 22% of stroke patients receive inpatient rehabilitation after hospitalization, and Black patients face a 29% higher chance of being sent home instead.
Glucosamine, a popular joint supplement taken by millions, may raise mortality risk by 25 percent in people already diagnosed with dementia, researchers.
Blast-induced brain injuries can silently raise stroke risk years later, yet often show nothing on standard scans, researchers warn.
Teens with traumatic brain injuries face 30% higher rates of depression and anxiety years later, requiring long-term mental health monitoring.
Returning baby reflexes in healthy older adults may signal nearly double the dementia risk within seven years, a 19-year study of 870+ people found.
Dementia care costs exceed $750,000 per family, but early financial planning and brain-healthy lifestyle changes can help reduce this devastating burden.
Canadian scientists are racing to become the first to diagnose CTE in living patients, potentially saving thousands from a brain disease currently only.
New Mayo Clinic research reveals Alzheimer's brain changes accelerate in your late 50s, decades before memory loss appears, reshaping early detection.
Low blood pressure triples Alzheimer's risk in a major study of 800,000 adults, revealing surprising heart-brain connections beyond hypertension.
Deep brain stimulation for Parkinson's is safer than common spine surgeries, yet remains underused due to myths about brain surgery risks.
Dementia encompasses hundreds of conditions beyond memory loss, with new research linking environmental lead exposure to cognitive decline in older adults.
Montara Therapeutics receives $1M to develop a brain-targeted Parkinson's drug that could safely clear toxic proteins without dangerous side effects.
New research finds Chlamydia pneumoniae bacteria in eye tissue may trigger brain inflammation linked to Alzheimer's disease progression.
Northwestern scientists developed gene therapy that reverses Parkinson's involuntary movements without surgery, offering hope to 80% of patients who.
PET brain scans can now predict which Alzheimer's patients will benefit from new drugs, potentially ending trial-and-error treatment approaches.
New research reveals that exercise, diet, and managing diabetes could be your most powerful tools to prevent dementia and protect brain health.
Early-onset Parkinson's strikes before age 50 during peak career years, but recognizing subtle warning signs can dramatically improve outcomes.
Scientists discover a molecular switch that fuels brain inflammation in Alzheimer's disease, offering a new treatment target that protects nerve.
